Member Info for GeordieShores

Stockopedia gives 0 for Quality and 0 overall.

REE have £109k in the bank £1.27m debt.

A raise was inevitable anyway, yesterday's news just helps increase the price they can do the raise at. This is obviously a good thing, but the £109k isn't going to last long. Sometimes discounts can be 70%, so my estimate is 1p for whoever is willing to lend them a boat load of money to keep the lights on.

Again, that might not be a bad thing, but it takes years before anything will be dug out of the [rare] earth- just asked SOLG holder's...

Fundamentals do not always matter. Collaborations do not always generate sales, and even when they do, it can take some time for cash to arrive.

Cash / funding always matters.

Like I say, results out in two weeks.

We will have a much clearer picture in two weeks time.

Date: Monday, September 29th 2025

Event: Full Year 2025 Renalytix PLC Earnings Release

Cash is not bad and they don't have any debt, but they need some sales.

Need to figure out what monthly cash burn is. Here's some current figures from Stockopedia:-

TTM (Trailing Twelve Months) figures:

$9.69m cash

$6.59m working capital

$-1.49m net debt

Note: A negative net debt number means more cash than debt (i.e.net cash).

TTM revenue $2.37m.

Forecast 2025 revenue shown as $10.6m

Forecast 2026 revenue $19.6m.

Either fantastic timing or UBS knew something on Friday before RNS was issued yesterday.

Imagine that, buying 5% of the company a day before an RNS made the price shoot up..

Not suggesting anything...

Had several live quotes for 10,000 - last was 9.45p to buy.

People who are saying you can't buy and no quote are talking rubbish (unless they just have a rubbish broker).

Marty, "Estimates of 100 to 200 million in predicted revenue".

Where did you get those figures from. My posts use facts.

Cannot see any mention of income or expected sales figures from today's news.

Revenue in 2024 was $2.29m with a loss of $41m.

Okay, they have $9m cash in bank (not bad), but how quickly is todays announcement going to change that revenue figure?

Stockopedia gives this a Rank of 3 out of 100.

Thay had $74m cash in 2021, that reduced to $44m in 2022, $26m in 2023 and $5m in 2024. Currently have $9m cash.

They were worth $95m in 2021, now minus $1.3m (before this announcement).

Cannot see any mention of income or expected sales figures from today's news. Just another collaboration which Pharma companies love to mention, without backing them up with actual monetary figures.

So what are expected sales??

Regardless of the Argentinians, definitely worth a lot more than the current share price (but would still be nice if the Argies paid up).

Mannnan, you wrote "Placing price 0.30 but i bought some at 0.25 strong buy now".

Erm.. the placing price was 0.1.

Got to love the part of the RNS when the BOD basically said the rumours on 20th June about digital assets and Bit Coin was not true. However, the BOD has since done a review and decided that digital assets and bit coin are a great idea. How do they get away with this?

As usual, a classic case of "inflate the share price anyway you can before a placing".

If bit coin falls 20% the percentage of the placing they spend on bit coin also falls 20%. Obvious you might say, but with bit coin at almost record highs, and trump tariffs uncertain, it's a risk strategy (but then so is investing in this company).

H

Anyone remember Fanablr?? Not saying this is the same thing, but this is a similar company that has ran into difficulties.

https://www.fintechfutures.com/lendtech/travelex-owner-finablr-reveals-1bn-hidden-debt

Stockopedia shows net debt of -£38 million in 2024. A negative debt figure means more cash than debt.

Where did £38m go??

Cash was shown as £48 million.

Book value was £43 million and net fixed assets were £27 million.

Stockopedia still shows a "Health trend" of 4 on a scale of 0 - 9.

Okay, so £2.1m in 3 months = £700k per months.

This was foretold in the Jan 25 trading update

"The cash cost base for the last quarter of FY2024 was approximately £750k per month, and the expected cost base for FY2025 is approximately £8m for the year".

£8m for the year is £666k pm so spend has almost been what they said. Obvious problem is income is nowhere near what is required to pay the bills.

As some have already said, the cash they have won't last long and based on situation they HAVE to start the administration process soon.

Burned through £2.1 million in 4 months = spending £500k per month.

2024 turnover only £1m, but annual cost base £8m.

And CEO takes £447k ! Which is 99% above industry average

https://finance.yahoo.com/news/increases-ceo-compensation-might-put-072836639.html

This company isn't a medical research company or exploration company, they are an advertising company so should be making money selling advertising not losing it by paying the CEO half of the annual turnover.

It should be illegal to run a company like this, when it is obvious what has been happening and what is going to happen.

Share price down 84% says it all really.

Remember the offer price doesn't have to be as high as the maximum price in the last 12 months (as some people sometimes mistakenly think), but it must be "fair and reasonable". The Takeover Code does stipulate rules around pricing, including that the offer price must not be less than the highest price paid by the offeror in the 12 months before the offer period.

So if the bidder has not bought any shares in the last 12 months they can make an offer at any price that is deemed "reasonable", so 36p could be reasonable. Why some people on here are suggesting it will be 70p or £1 I am not quite sure.

A mass of debt and Oil and Gas in turmoil.

The winners will be those last week who bought at the 22p mark and who are already up over 50% in a week.

Earlier someone asked why would they need to do a placing now they have this J&J contract?

They burned through £8m in 12 months, so are spending approx £600k pm. No one knows how much they are getting upfront or monthly?? All very well this being J&J, but HOW MUCH?? Is this a loss-leader??? Give it away cheap so other similar companies will come on board.

Very much up in the air with no monetary amounts disclosed.

The J&J contract is only for 12 months. Might he extended, might not be.

The success of this will depend on how many patients sign up for the portal and continue to use it whilst gaining benefits from doing so.

According to Stockopedia they are loosing £3 million a year. If the J&J contract is less than that and if they don't have any more customers they will still be loss making.

Nothing goes up 700% in a day and then continues to climb the next day..

Ask on here shown as 4.2p so spread 19% as ii quoted 5p to buy.

Used ii to get quote at 16.29 for 50,000 shares which is market size.

Price to buy was 5p total cost £2,500. I got the 15 second countdown to accept but I didn't execute.

Be interesting to see what they open at.

Haven't seen anything go up as much intra day in a long time...